期刊文献+

从临床麻醉医师的角度解读药代学-药效学 被引量:2

下载PDF
导出
摘要 对临床医师来说,药理研究的最终目的是指导临床合理用药。自乙醚首次应用以来,麻醉学已走过170年历史,期间各类新药交替出现又逐步淘汰,我们对这些药物少有自己的见解,其中原因与临床和药理学基础知识脱节不无关系。药代学(PK)指药物在体内的处置过程;药效学(PD)指药物的药理作用及机制,反映药物进入人体后产生何种作用。
出处 《上海医学》 CAS CSCD 北大核心 2011年第10期723-727,共5页 Shanghai Medical Journal
基金 国家自然科学基金(30972841、30901394) 上海市科学技术委员会科技引导类项目(10411965400)资助
  • 相关文献

参考文献19

  • 1SHAFER S L, SIEGEL L C, COOKE J E, et al. Testing computer-controlled infusion pumps by simulation[J]. Anes- thesiology, 1988, 68(2): 261-266.
  • 2SHAFER S L, GREGG K M. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump[J]. J Phar- macokinet Biopharm, 1992, 20(2) : 147-169.
  • 3WAGNER J G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetie parameters from the coefficients and exponents of polyexponential equa- tions which have been fitted to the data[J]. J Pharmacokinet Biopharm, 1976, 4(5) : 443 -467.
  • 4ZHANG M Z, YU Q, HUANG Y L, et al. A comparison between bispectral index analysis and auditory-evoked poten- tials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol[J]. Eur J Anaesthesiol, 2007, 24(10): 876-881.
  • 5牛静,俞青,张马忠,王珊娟.两个血浆-效应室平衡速率常数值用于靶控丙泊酚效应位浓度对血流动力学的影响[J].上海医学,2009,32(1):43-45. 被引量:7
  • 6俞青 张马忠 王祥瑞.血浆效应室消除速率常数的意义和临床应用[J].上海交通大学学报(医学版),2006,26:53-55.
  • 7俞青,张马忠,王祥瑞,王珊娟,杭燕南.术前患者异丙酚血浆-效应室平衡速率常数的估测[J].中华麻醉学杂志,2006,26(6):498-500. 被引量:10
  • 8BEAL S L, SHEINER L B. NONMEM Users Guide V[M]. San Francisco: NONMEM Project Group University of Cali- fornia, 1998.
  • 9SONGJC, ZHANGMZ, LUZJ, et al. The effects of ob- structive jaundice on the pharmacodynamics of propofol: does the sensitivity of intravenous anesthetics change among icteric patients? [J]. Acta Anaesthesiol Scand, 2009, 53(10): 1329-1335.
  • 10张凌,张马忠,杭燕南.等效线图解法在药效学相互作用研究中的应用[J].国际麻醉学与复苏杂志,2007,28(5):472-476. 被引量:9

二级参考文献78

共引文献33

同被引文献30

  • 1杨震宇.罗哌卡因与布比卡因在腰麻硬膜外麻醉联合阻滞中的效果[J].求医问药(下半月),2013(1):458-459. 被引量:1
  • 2俞青,张马忠,王祥瑞,王珊娟,杭燕南.术前患者异丙酚血浆-效应室平衡速率常数的估测[J].中华麻醉学杂志,2006,26(6):498-500. 被引量:10
  • 3黄咏磊,周仁龙,张马忠,王珊娟,王祥瑞,杭燕南.罗库溴铵相关药代学和药效学参数的测定[J].临床麻醉学杂志,2006,22(12):904-906. 被引量:5
  • 4赵丹.静脉麻醉药药代学研究[J].中外健康文摘,2013,8(15):117一118.
  • 5Sheinner LB,Stanski DR,Vozeh S. Simultaneous modeling of pharmacokinetcs and pharmacodynamics:applocation to d-tubocurarine[J].Clinical Pharmacology and Therapeutics,1979,(03):358-371.
  • 6Lin L,Zhang JW,Huang Yue. Population pharmacokinetics of intravenous bolus etomidate in children over 6months of age[J].Pediatric Anesthesia,2012,(04):318-326.
  • 7Youngs EJ,Shafer SL. Basic pharmacokinetic and pharmacodynamic principles[A].Baltimore,William and Wilkins,1997.10-26.
  • 8Zhang MZ,Yu Q,Huang YL. A comparison between bispectral index analysis and auditory evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol[J].European Journal of Anaesthesiology,2007,(10):876-881.doi:10.1017/S0265021507000890.
  • 9Minto CF,Schnider TW,Gregg KM. Using the time of maximam effect site concentration to combine pharmacokinetics and pharmacodynamics[J].Anesthesiology,2003,(02):324-333.
  • 10Scott JC,Stanski DR. Decreased fentanyl and alfentanil dose requirements with age[J].A simultaneous pharmacokinetic and pharmacodynamic evaluation J Pharm Exp Ther,1987,(01):159-166.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部